<DOC>
	<DOCNO>NCT00003446</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness trimetrexate glucuronate , fluorouracil , leucovorin treat patient recurrent metastatic colorectal cancer .</brief_summary>
	<brief_title>Chemotherapy Treating Patients With Recurrent Metastatic Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate tumor response duration , one-year progression-free survival , one-year overall survival patient recurrent metastatic colorectal carcinoma treat trimetrexate glucuronate , fluorouracil , leucovorin calcium . OUTLINE : Patients receive trimetrexate glucuronate ( TMTX ) IV 1 hour day 1 . Beginning 18 hour TMTX dosage , patient receive leucovorin calcium ( CF ) IV 2 hour . Immediately completion CF infusion , patient receive IV bolus injection fluorouracil ( 5-FU ) . Beginning 4 hour 5-FU infusion , patient receive oral CF every 6 hour 6 dos . Treatment repeat every 14 day absence disease progression unacceptable toxicity long disease remain inoperable . Patients follow every 3 month 1 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 18-45 patient accrue study within 15 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Trimetrexate</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm colorectal carcinoma Inoperable advance recurrent metastatic disease Measurable disease outside previously irradiated area No CNS metastases PATIENT CHARACTERISTICS : Age : 18 74 Performance status : WHO 01 Life expectancy : More 12 week Hematopoietic : WBC great 4,000/mm3 Platelet count great 100,000/mm3 Hepatic : Bilirubin le 1.25 time upper limit normal ( ULN ) SGOT le 1.25 time ULN Albumin great 3.5 g/dL Renal : Creatinine clearance great 70 mL/min Cardiovascular : No history congestive heart failure , myocardial infarction within past 6 month , active ischemic heart disease , uncontrolled hypertension Other : No weight loss 10 % last 2 month No prior malignancy except curatively treat carcinoma situ cervix nonmelanoma skin cancer No history alcohol abuse No uncontrolled medical psychiatric disease Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent filgrastim ( GCSF ) Chemotherapy : No prior chemotherapy advance disease Recovered prior adjuvant therapy No concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior radiotherapy advanced disease Surgery : See Disease Characteristics Other : No concurrent therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>September 2001</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
</DOC>